HomeProductsBioactive CompoundsMetabolic EnzymesVD/VDRMaxacalcitol
Chemical structure of CAS 103909-75-7

Maxacalcitol

In Stock•Starting at $62 for 1 mg•Purity ≥ 98%
CAS No.103909-75-7
MDL No.MFCD00871502
MFC26H42O4
MW418.60
InChI KeyDTXXSJZBSTYZKE-ZDQKKZTESA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98+%$62In Stock
5 mg98+%$248In Stock
10 mg98+%$396In Stock
25 mg98+%$877In Stock
50 mg98+%$1489In Stock
100 mg98+%$2381In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Maxacalcitol is an organic compound.

CAS No.103909-75-7
Product NameMaxacalcitol

Associated Conditions

secondary hyperparathyroidism
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • Vol. 24, Issue 8 • 2009
PMID: 19297354DOI: 10.1093/ndt/gfp117

Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.

International journal of dermatology • Vol. 46, Issue 12 • 2007
PMID: 18173537DOI: 10.1111/j.1365-4632.2007.03347.x

Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D3, maxacalcitol, on the proliferation of pancreatic cancer cell lines.

The Journal of steroid biochemistry and molecular biology • Vol. 97, Issue 1-2 • 2005
PMID: 16039115DOI: 10.1016/j.jsbmb.2005.06.021

Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients.

Clinical and experimental nephrology • Vol. 9, Issue 3 • 2005
PMID: 16189633DOI: 10.1007/s10157-005-0363-x

Documentation

Similar Products